The BBB poses a significant challenge in the treatment of brain tumors and other central nervous system (CNS) malignancies. This barrier restricts the delivery of many chemotherapeutic agents to the brain, limiting their effectiveness. Drugs that are effective against systemic cancers often fail to penetrate the BBB in sufficient concentrations to affect tumor cells in the brain.
